The Guardian Australia
·general
·1 hour ago
Trump administration move to reclassify cannabis sparks confusion
The Trump administration partially reclassified cannabis last week, moving state-regulated medical products and future FDA-approved cannabis drugs from Schedule I to Schedule III. However, experts say the limited rescheduling creates confusion rather than clarity, affecting only prospective FDA approvals while leaving existing cannabis pharmaceuticals unchanged. Industry observers noted the move signals pro-cannabis sentiment but raises questions about practical implementation.
Summary by Glance · The Guardian Australia
Newer
Next
Loving doing this? 🎉
Take it further — get the full app and never miss a moment of what's happening in Australia.
Breaking news alerts
Instant lock-screen notifications the moment big stories break across Australia.
Australian news & events
Politics, sport, weather, local events — all in one swipeable feed, updated around the clock.
Stay ahead of the news cycle
30-second summaries so you're always informed, even on your busiest days.
Loading article…
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
✨
Ask AI